Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

BACKGROUND: HCV treatment uptake has drastically increased in HIV-HCV coinfected patients in France since direct-acting antiviral (DAA) treatment approval, resulting in HCV cure in 63% of all HIV-HCV patients by the end of 2015. We investigated the impact of scaling-up DAA on HCV prevalence in the w...

Descripción completa

Detalles Bibliográficos
Autores principales: Virlogeux, Victor, Zoulim, Fabien, Pugliese, Pascal, Poizot-Martin, Isabelle, Valantin, Marc-Antoine, Cuzin, Lise, Reynes, Jacques, Billaud, Eric, Huleux, Thomas, Bani-Sadr, Firouze, Rey, David, Frésard, Anne, Jacomet, Christine, Duvivier, Claudine, Cheret, Antoine, Hustache-Mathieu, Laurent, Hoen, Bruno, Cabié, André, Cotte, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733872/
https://www.ncbi.nlm.nih.gov/pubmed/29249202
http://dx.doi.org/10.1186/s12916-017-0979-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733872/
https://www.ncbi.nlm.nih.gov/pubmed/29249202
http://dx.doi.org/10.1186/s12916-017-0979-1

Ejemplares similares